Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study

Lars Sävendahl, Marc Maes, Kerstin Albertsson-Wikland, Birgit Borgström, Jean-Claude Carel, Séverine Henrard, Niko Speybroeck, Muriel Thomas, Gladys Zandwijken, Anita Hokken-Koelega
  • The Journal of Clinical Endocrinology & Metabolism, February 2012, Endocrine Society
  • DOI: 10.1210/jc.2011-2882
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Séverine Henrard and Professor Lars Sävendahl